Characteristics of Patients Treated With Secukinumab for Moderate to Severe Plaque Psoriasis
Clinical trial NCT05650060 · COMPLETED
Trial details
- NCT number
- NCT05650060
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-20
- Primary completion
- 2021-12-23
- Enrollment
- 163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.